Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 13, 2018 16:30 ET | Source: Teligent, Inc.

Teligent, Inc. to Present at the Oppenheimer 28th Annual Healthcare Conference on Tuesday March 20, 2018

BUENA, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Oppenheimer 28th Annual...
March 12, 2018 16:30 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for Fourth Quarter 2017 Results

BUENA, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...
March 05, 2018 16:30 ET | Source: Teligent, Inc.

Teligent, Inc. to Present at the Raymond James 39th Annual Institutional Investors Conference on Wednesday March 7, 2018

BUENA, N.J., March 05, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James 39th Annual...
February 14, 2018 09:31 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Lotion USP (Augmented), 0.05%

BUENA, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
January 26, 2018 08:40 ET | Source: Teligent, Inc.

Teligent, Inc. Announces the Appointment of Damian Finio as Chief Financial Officer

BUENA, N.J., Jan. 26, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced today that Damian Finio has been appointed Chief...
January 03, 2018 15:55 ET | Source: Teligent, Inc.

Teligent, Inc. to Present at the J.P. Morgan 36th Annual Healthcare Conference January 10th

BUENA, N.J., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the J.P. Morgan 36th Annual Healthcare...
November 22, 2017 08:30 ET | Source: Teligent, Inc.

Teligent, Inc. Announces First FDA Generic Approval of Hydrocortisone Butyrate Lotion 0.1%

BUENA, N.J., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
November 21, 2017 08:30 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Erythromycin Topical Solution USP, 2%

BUENA, N.J., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
November 10, 2017 09:20 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%

BUENA, N.J., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
November 06, 2017 16:05 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Third Quarter 2017 Results

BUENA, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter...